𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients

✍ Scribed by Qian An; Yong Liu; Yanning Gao; Jinfeng Huang; Xiaoli Fong; Ling Li; Dechao Zhang; Shujun Cheng

Book ID
117467545
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
97 KB
Volume
188
Category
Article
ISSN
0304-3835

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Alterations of CDKN2 (p16) in non-small
Alterations of CDKN2 (p16) in non-small cell lung cancer
✍ Sven De Vos; Carl W. Miller; Seisho Takeuchi; Adrian F. Gombart; Steve K. Cho; H πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 567 KB

## Abstract The cyclin‐dependent kinase inhibitor known as __p16__ (__CDK41, CDKN2, INK4A, MTS1__) has been proposed as a tumor suppressor gene on chromosome segment 9p21. We have evaluated __CDKN2__ alterations in 34 non‐small cell lung cancers (NSCLCs) with matched normal tissue controls and in 9

p16INK4A and CDH13 hypermethylation in t
p16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients
✍ Paola Ulivi; Wainer Zoli; Daniele Calistri; Francesco Fabbri; Anna Tesei; Marco πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 131 KB

## Abstract Aberrant promoter hypermethylation of several known or putative tumor suppressor genes occurs frequently during the etiopathogenesis of lung cancer and is a promising tool for cancer detection. In the present study, promoter hypermethylation of __p16^INK4A^__ and __CDH13__ genes was inv